Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
3.970
-0.080 (-1.98%)
At close: Sep 11, 2026, 4:00 PM EDT
3.841
-0.130 (-3.26%)
After-hours: Sep 11, 2026, 7:57 PM EDT

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
7176281835
Market Cap Growth
-66.87%-72.15%627.66%-51.77%-50.18%13.53%
Enterprise Value
3125351027
Last Close Price
3.9713.2058.6515.7544.4093.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
33.8224.39133.1537.5668.9748.92
PB Ratio
1.386.628.073.172.312.71
P/TBV Ratio
1.496.428.223.292.362.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
EV/Sales Ratio
15.6217.46114.3321.5839.4437.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Debt / Equity Ratio
0.020.040.020.060.010.01
Net Debt / Equity Ratio
-0.81-0.71-0.84-0.49-0.80-0.89
Net Debt / EBITDA Ratio
0.480.161.140.210.942.09
Net Debt / FCF Ratio
0.470.181.280.221.242.92
Asset Turnover
0.030.110.080.040.020.09
Inventory Turnover
----2.112.39
Quick Ratio
9.561.566.105.9932.7978.90
Current Ratio
10.602.327.188.0435.9681.18
Return on Equity (ROE)
-162.77%-232.15%-112.36%-130.18%-71.35%-73.16%
Return on Assets (ROA)
-81.30%-111.49%-59.56%-73.59%-39.21%-44.17%
Return on Capital Employed (ROCE)
-170.40%-433.80%-73.30%-228.20%-86.60%-43.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-117.86%-69.13%-9.38%-78.45%-41.27%-11.39%
FCF Yield
-113.81%-60.84%-8.09%-69.63%-27.98%-11.28%
Buyback Yield / Dilution
-32.40%-45.34%-87.24%-12.38%-34.02%-58.34%
SEC Filings: 10-K · 10-Q